Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) Interest Expenses (2016 - 2025)

Apyx Medical's Interest Expenses history spans 11 years, with the latest figure at $1.4 million for Q4 2025.

  • For Q4 2025, Interest Expenses fell 14.88% year-over-year to $1.4 million; the TTM value through Dec 2025 reached $5.6 million, down 5.38%, while the annual FY2025 figure was $5.6 million, 5.38% down from the prior year.
  • Interest Expenses reached $1.4 million in Q4 2025 per APYX's latest filing, roughly flat from $1.4 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $1.7 million in Q4 2024 to a low of $1000.0 in Q4 2021.
  • Average Interest Expenses over 5 years is $699950.0, with a median of $564000.0 recorded in 2023.
  • Peak YoY movement for Interest Expenses: tumbled 88.0% in 2021, then soared 58400.0% in 2023.
  • A 5-year view of Interest Expenses shows it stood at $1000.0 in 2021, then skyrocketed by 200.0% to $3000.0 in 2022, then surged by 37100.0% to $1.1 million in 2023, then soared by 48.12% to $1.7 million in 2024, then decreased by 14.88% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for APYX's Interest Expenses are $1.4 million (Q4 2025), $1.4 million (Q3 2025), and $1.4 million (Q2 2025).